Schmidt A, Lorkowski S, Seidler D, Breithardt G, Buddecke E
Leibniz-Institute of Arteriosclerosis Research, University of Muenster, Domagkstrasse 3, D-48149 Muenster, Germany.
Eur J Clin Invest. 2006 Jul;36(7):473-82. doi: 10.1111/j.1365-2362.2006.01658.x.
Transforming growth factor (TGF-beta(1)) is postulated to play an important role in maintaining the structure and function of arterial tissue and protection against development of arteriosclerosis. The TGF-beta(1)-induced production of a stable extra-cellular matrix-rich plaque phenotype is suggested to be part of the protection against a switch to an unstable rupture-prone arteriosclerotic plaque.
This study addresses the question of whether the expression profile and the type of extra-cellular matrix (ECM) generated by TGF-beta(1) stimulation have the structural feature of a fibril-rich stable matrix. Seventeen genes codings for ECM components of human coronary smooth muscle cells (SMCs) after a 24-h stimulation by TGF-beta(1) have been analyzed.
Real-time RT-PCR was used to quantify the mRNA of genes under investigation. It was found that after TGF-beta(1) stimulation (a) the up-regulation of COL1A1-specific mRNA was associated with increased [(3)H]proline incorporation into the alpha-1 and -2 chains of collagen type I, (b) the up-regulation of biglycan- and syndecan-1-specific mRNA corresponded to an increased [(35)S]sulphate and [4,5-(3)H]leucine incorporation into the biglycan molecule and to an increase of syndecan-1 protein, (c) the up-regulated FGF-2 gene accounted predominantly for the ECM-bound subfraction of FGF-2-protein and (d) fibronectin and thrombospondin exhibited a significantly higher mRNA level. In contrast collagen XIV, a minor collagen type, and the proteoglycan decorin were down-regulated. The down-regulated decorin changed its structure by elongation and reduced GlcA to IdoA epimerization of the dermatan sulphate side-chain as judged by [(35)S]sulphate metabolic labelling experiments. No significant changes in response to TGF-beta(1) were observed for the collagen types III, VI and XVI, for versican, perlecan and the syndecans-2 and -4.
It was concluded from the data that the TGF-beta(1)-induced formation of a highly specific multicomponent extra-cellular matrix on coronary arterial SMCs could provide in vivo mechanical strength to the neointima in arteriosclerotic lesions and to the fibrous cap overlying the lipid core.
据推测,转化生长因子(TGF-β(1))在维持动脉组织的结构和功能以及预防动脉硬化发展方面发挥着重要作用。TGF-β(1)诱导产生富含稳定细胞外基质的斑块表型,这被认为是预防转变为不稳定的易破裂动脉硬化斑块的保护机制的一部分。
本研究探讨了TGF-β(1)刺激后所产生的细胞外基质(ECM)的表达谱及类型是否具有富含纤维的稳定基质的结构特征。对TGF-β(1)刺激24小时后的人冠状动脉平滑肌细胞(SMC)的17种编码ECM成分的基因进行了分析。
采用实时RT-PCR对所研究基因的mRNA进行定量。结果发现,TGF-β(1)刺激后:(a)COL1A1特异性mRNA的上调与[³H]脯氨酸掺入I型胶原的α-1和α-2链增加相关;(b)双糖链蛋白聚糖和多功能蛋白聚糖-1特异性mRNA的上调分别对应于[³⁵S]硫酸盐和[4,5-³H]亮氨酸掺入双糖链蛋白聚糖分子增加以及多功能蛋白聚糖-1蛋白增加;(c)上调的FGF-2基因主要构成了与ECM结合的FGF-2蛋白亚组分;(d)纤连蛋白和血小板反应蛋白的mRNA水平显著升高。相比之下,次要的胶原类型XIV以及核心蛋白聚糖表达下调。通过[³⁵S]硫酸盐代谢标记实验判断,下调的核心蛋白聚糖通过延长改变了其结构,并使硫酸皮肤素侧链的葡糖醛酸(GlcA)向艾杜糖醛酸(IdoA)的差向异构化减少。对于III型、VI型和XVI型胶原、多功能蛋白聚糖、基底膜聚糖以及多功能蛋白聚糖-2和-4,未观察到对TGF-β(1)的显著反应。
从这些数据得出的结论是,TGF-β(1)诱导冠状动脉SMC形成高度特异性的多组分细胞外基质,可为动脉硬化病变中的新生内膜以及脂质核心上方的纤维帽提供体内机械强度。